<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Cutting-edge CAR-T cancer therapy is now made in India — at one-tenth the cost

Default sub title

minute read

by Nature | March 21, 2024
placeholder

A small Indian biotechnology company is producing a home-grown version of a cutting-edge cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy that was pioneered in the United States. 

Topics: Press Coverage